Salomon & Ludwin, LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLP and the CUSIP is 81369Y308. A total of 853 filers reported holding SELECT SECTOR SPDR TR in Q3 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
Salomon & Ludwin, LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$11,796,807
-6.3%
171,193
+0.9%
1.23%
-8.1%
Q2 2023$12,588,502
+3.0%
169,725
+3.8%
1.34%
-8.1%
Q1 2023$12,217,650
+3.3%
163,534
+3.0%
1.46%
-2.9%
Q4 2022$11,832,368
+8.5%
158,717
-2.9%
1.50%
-8.3%
Q3 2022$10,904,000
-1.9%
163,399
+6.1%
1.64%
-4.9%
Q2 2022$11,120,000
-0.8%
154,059
+4.3%
1.72%
+5.8%
Q1 2022$11,206,000
-0.1%
147,662
+1.5%
1.62%
+2.3%
Q4 2021$11,217,000
+14.7%
145,471
+2.4%
1.59%
+4.4%
Q3 2021$9,778,000
+3.2%
142,035
+4.9%
1.52%
+2.3%
Q2 2021$9,475,000
+4.1%
135,413
+1.6%
1.49%
-3.8%
Q1 2021$9,105,000
+0.5%
133,287
-0.8%
1.54%
-8.0%
Q4 2020$9,061,000
-1.0%
134,335
-5.9%
1.68%
-11.8%
Q3 2020$9,150,000
+0.4%
142,744
-8.2%
1.90%
-3.0%
Q2 2020$9,117,000
+5.5%
155,469
-2.0%
1.96%
-11.7%
Q1 2020$8,643,000
-17.3%
158,667
-4.4%
2.22%
+7.2%
Q4 2019$10,454,000
-3.8%
165,985
-6.2%
2.08%
-5.6%
Q3 2019$10,866,000
+3.4%
176,908
-2.3%
2.20%
+3.5%
Q2 2019$10,511,000
+1.7%
181,009
-1.7%
2.12%
-0.2%
Q1 2019$10,334,000
+5.4%
184,175
-4.6%
2.13%
-6.0%
Q4 2018$9,801,000193,0012.26%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q3 2021
NameSharesValueWeighting ↓
Wechter Feldman Wealth Management, Inc. 82,241$4,480,00010.94%
SEARCY FINANCIAL SERVICES INC /ADV 136,762$7,449,00010.57%
Chicago Wealth Management, Inc. 146,796$7,996,0009.45%
SWARTHMORE GROUP INC 23,450$1,277,0006.76%
JANICZEK WEALTH MANAGEMENT, LLC 219,956$11,981,0006.75%
Private Wealth Advisors, LLC 142,418$7,758,0006.36%
Capital Advantage, Inc. 262,606$15,888,0006.21%
Conservest Capital Advisors, Inc. 631,878$34,418,0005.70%
SL ADVISORS, LLC 23,921$1,303,0005.67%
Danda Trouve Investment Management, Inc. 49,362$2,689,0005.58%
View complete list of SELECT SECTOR SPDR TR shareholders